Kornelia Griessmann

Title: Kornelia Griessmann: Pioneering Innovations in Pharmaceutical Dosage Forms

Introduction

Kornelia Griessmann, an inventive mind based in Aachen, Germany, has made significant contributions to the field of pharmaceuticals. As a dedicated inventor, she holds two patents that showcase her commitment to developing safe and effective pharmaceutical solutions.

Latest Patents

Griessmann's latest patents include the "Oxidation-stabilized tamper-resistant dosage form," which features a thermoformed pharmaceutical dosage design with a breaking strength of at least 300 N. This innovative dosage form is designed to enhance the safety and reliability of pharmaceutical products, providing an essential advancement in tamper-resistant medication technology.

Career Highlights

Throughout her career, Kornelia has played an integral role at Grünenthal GmbH, a prominent pharmaceutical company known for its commitment to innovation and medication safety. Her work has not only contributed to the company's objectives but has also significantly impacted the industry by addressing crucial safety concerns related to dosage forms.

Collaborations

Kornelia Griessmann has collaborated with talented coworkers such as Lutz Barnscheid and Eric Galia. These partnerships have fostered a productive environment that encourages the exchange of ideas and expertise, enabling the launch of groundbreaking pharmaceutical solutions.

Conclusion

Kornelia Griessmann stands out as an influential inventor in the pharmaceutical sector. Her patents, particularly her work on oxidation-stabilized tamper-resistant dosage forms, reflect her innovative spirit and dedication to improving medication safety. As she continues her journey at Grünenthal GmbH, the impact of her work is expected to resonate throughout the industry, paving the way for future advancements.